Key Moments
#46–Chris Masterjohn, Ph.D.: Pathways to health and disease (NAD, sirtuins, methylation, choline...
Key Moments
Dr. Chris Masterjohn discusses choline, fatty liver, methylation, MTHFR, COMT, and NAD+ precursors for health.
Key Insights
Choline is an essential nutrient vital for fat transport from the liver, and its deficiency can lead to non-alcoholic fatty liver disease (NAFLD).
TMAO, a metabolite linked to cardiovascular risk, is produced from choline and carnitine by gut bacteria, but its overall impact is debated, especially when considering fish consumption.
MTHFR and COMT genetic variations influence methylation, affecting nutrient requirements (like choline) and mental states, highlighting individualized nutritional needs.
NAD+ precursors like NR are believed to increase intracellular NAD+ by first being metabolized by the liver into nicotinamide, which then circulates to other tissues.
Supplementation with NAD+ precursors may risk depleting methyl group supply due to the liver's detoxification processes, suggesting co-supplementation with methyl donors like TMG or creatine.
Creatine synthesis is a major consumer of methyl groups, and supplementation can alleviate the burden on the methylation cycle, potentially benefiting those with MTHFR variations or mental health concerns.
THE CRITICAL ROLE OF CHOLINE AND THE NAFLD EPIDEMIC
Chris Masterjohn, Ph.D., and Peter Attia MD discuss choline's essential role as a methyl donor, neurotransmitter component (acetylcholine), and integral part of cell membranes (phosphatidylcholine). Choline deficiency is directly linked to non-alcoholic fatty liver disease (NAFLD) because phosphatidylcholine is crucial for the formation of VLDL particles that transport triglycerides out of the liver. When TPN (total parenteral nutrition) patients didn't receive choline, they developed fatty liver, revealing its essentiality. Animal studies consistently show that sufficient choline can prevent or reverse fatty liver, regardless of the cause (e.g., high sucrose, alcohol, or fat diets).
ADDRESSING CHOLINE DEFICIENCY AND NAFLD TREATMENT
The average choline intake is insufficient for many, especially those with genetic predispositions like certain MTHFR variants, who might need up to 1200 mg daily. While challenging, this amount can be achieved through choline-rich foods like liver and egg yolks (one egg contains ~130 mg), or through supplementation, ideally with phosphatidylcholine. The discussion highlights that NAFLD's increasing prevalence likely tracks with obesity and visceral adiposity, which continuously floods the liver with fatty acids. The complexity of disentangling the effects of fructose reduction versus weight loss in NAFLD resolution is acknowledged, as many dietary changes implicitly involve multiple physiological shifts.
TMAO: A MISUNDERSTOOD METABOLITE?
Trimethylamine N-oxide (TMAO), initially flagged as a cardiovascular risk factor by Cleveland Clinic research, is naturally abundant in fish and can be produced from choline and carnitine by gut bacteria. However, the prevailing epidemiological evidence, which links fish consumption to positive cardiovascular outcomes, contradicts the idea that TMAO is inherently harmful. While high supplemental doses of choline salts (like choline bitartrate) can significantly elevate plasma TMAO and potentially impact clotting, the TMAO response from choline in whole foods like eggs is much lower and highly variable among individuals, suggesting a strong influence of the gut microbiome and absorption efficiency.
THE COMPLEXITY OF DIETARY FATS AND FATTY LIVER
The discussion delves into how different types of dietary fats—saturated (SFA), monounsaturated (MUFA), and polyunsaturated (PUFA)—influence liver health. While a short-term human study indicated PUFAs might lead to less liver fat accumulation than SFAs, animal models suggest a long-term trade-off: PUFAs, due to their double bonds, are more susceptible to lipid peroxidation and oxidative stress. This vulnerability increases the risk of progressing from simple steatosis (fatty liver) to steatohepatitis (NASH), which involves inflammation and liver damage. The context of oxidative stress, such as that induced by alcohol metabolism, can further complicate how different fats behave in the liver.
MTHFR AND COMT: GENETICS OF METHYLATION
MTHFR is an enzyme crucial for the folate-dependent pathway of methylation, which converts homocysteine back to methionine. Common genetic variations (polymorphisms) in the MTHFR gene lead to a wide spectrum of enzyme activity, affecting about 90% of the population to some degree. Individuals with lower MTHFR activity often compensate by increasing choline utilization, making them more susceptible to choline deficiency. COMT is another enzyme that methylates catecholamines like dopamine, influencing mental flexibility (warrior phenotype) versus stability and sustained focus (worrier phenotype). These genetic variants predispose individuals to certain psychological traits or psychiatric conditions, emphasizing the interplay between genetics, nutrition, and mental health.
STRATEGIES FOR OPTIMIZING METHYLATION
For individuals with compromised MTHFR activity, key strategies include ensuring adequate choline intake (900-1200 mg/day), supporting MTHFR function with sufficient riboflavin (vitamin B2), and supplementing with creatine. Creatine synthesis is the largest consumer of methyl groups, and exogenous creatine can significantly reduce methyl demand, thereby preserving methyl pools for other essential functions like DNA repair and neurotransmitter methylation. Additionally, maintaining adequate methylfolate levels is important to prevent excessive loss of glycine (a methyl buffer) in the urine. These interventions can address issues such as elevated homocysteine, choline deficiency-related problems, and certain mental health concerns linked to imbalanced dopamine metabolism.
NAVIGATING THE NAD+ PRECURSOR LANDSCAPE
NAD+ (nicotinamide adenine dinucleotide) precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), are popular for their purported anti-aging benefits. However, the body does not absorb NAD+ directly; it must be synthesized from precursors. Oral NR is likely absorbed intact and then converted to nicotinamide in the liver, which is the primary circulating form used by other tissues to synthesize NAD+. NMN, having a charged phosphate group, is unlikely to be absorbed intact and is probably hydrolyzed to NR or nicotinamide before absorption. Studies indicate that while NR supplementation can increase NAD+ levels in tissues, a significant portion is metabolized by the liver. The flush associated with NAD+ injections is very different from that of niacin, likely due to a different receptor pathway involved in vasodilation and inflammation.
EFFICACY AND RISKS OF NAD+ SUPPLEMENTATION
While animal studies show promise for NAD+ precursors in increasing NAD+ levels, human trials have yet to demonstrate significant clinical benefits for metabolic endpoints like glucose or lipid metabolism. The rapid turnover of NAD+ in tissues like the small intestine and skin (40 times higher than muscle) suggests that benefits might first appear in these high-turnover areas (e.g., skin quality, gut health), which are difficult to measure in short-term studies. A major concern with high-dose NR or NMN supplementation is the potential depletion of the body's methyl group supply. As the liver detoxifies excess nicotinamide, it methylates it, pulling from the methionine and folate cycles. This drain on methyl groups may manifest as inconsistent energy levels or mood swings, and prophylactic co-supplementation with methyl donors like TMG (trimethylglycine) or creatine is a suggested strategy to mitigate this risk.
THE PHILOSOPHY OF EVIDENCE AND PERSONAL HEALTH
The discussion emphasizes the philosophical tension between needing conclusive, randomized controlled trial data for clinical endpoints and making personal health decisions based on mechanistic understanding, animal data, and individual responses. Chris Masterjohn advocates for a model-driven approach to health, where understanding underlying biochemistry—even if full human clinical endpoint data is lacking—can inform dietary and supplementation choices. He highlights the utility of RDAs (Recommended Dietary Allowances) as sound scientific baselines, albeit sometimes outdated or oversimplified in public messaging. The conversation touches on the nuanced debate surrounding the carbohydrate hypothesis of obesity, with Masterjohn aligning with the conventional view that obesity is a cause, rather than solely a consequence, of metabolic dysfunction.
Mentioned in This Episode
●Supplements
●Software & Apps
●Companies
●Organizations
●Books
●Drugs & Medications
●Concepts
●People Referenced
Common Questions
Choline is an essential nutrient that acts as a methyl donor, a component of the neurotransmitter acetylcholine, and a key part of phosphatidylcholine, a phospholipid in cell membranes. It is crucial for processes like fat transport out of the liver, and deficiency can lead to conditions like fatty liver disease. (Timestamp: 832 seconds)
Topics
Mentioned in this video
Published a paper in 1980 that coined the term 'NASH' (Non-alcoholic steatohepatitis), acknowledging fatty liver in non-alcoholic patients.
Prestigious medical journal that published a study on fructose reduction and NAFLD in Hispanic boys.
A newspaper that published an article on the power of the placebo effect.
Research institution where a paper on TMAO and atherosclerosis was published, which sparked a debate about choline.
An NAD+ precursor supplemented orally to increase NAD+ levels, believed to be more effective than nicotinamide for increasing hepatic NAD+ due to its metabolism pathway.
An amino acid that can act as a buffer for excess methyl groups and is depleted when methylfolate levels are low; supplementation has shown benefits for sleep and blood sugar.
An NAD+ precursor, suspected to be non-absorbable intact due to its charged phosphate group, likely cleaved to NR or nicotinamide before absorption.
A coenzyme vital for cellular energy metabolism and a substrate for sirtuins and PARPs, which are involved in DNA repair and longevity.
A compound crucial for energy metabolism and accounting for 45% of the body's methyl demand; supplementation can reduce the burden on methylation pathways.
A vitamin crucial for optimizing MTHFR enzyme activity, as MTHFR is a riboflavin-dependent enzyme with a lower affinity in certain polymorphisms.
A form of Vitamin B3 that activates the nicotinic acid receptor on immune cells, causing the 'niacin flush'.
An amino acid that serves as a precursor to choline and can significantly reduce fatty liver in animal models when abundant.
A food-derived protein source that, when consumed before exercise with vitamin C, has been shown to increase collagen synthesis in tendons.
Also known as betaine, a methyl donor derived from choline that can effectively lower homocysteine levels in patients with recycling issues.
An enzyme involved in the folate pathway, critical for converting folate into a usable form for methylation, often associated with genetic polymorphisms affecting its activity.
A sugar that, when consumed in high amounts, can contribute to fatty liver disease in animal models.
A class of enzymes that primarily repair DNA damage and require NAD+ as a substrate; often associated with aging and longevity.
A severe niacin deficiency disease characterized by '3 D's': dermatitis, diarrhea, and dementia, plus eventual death, serving as an extreme example of NAD+ depletion.
Intravenous nutrition that exposed choline deficiency in humans, leading to fatty liver disease when choline was omitted.
A monosaccharide believed to be a significant driver of NAFLD on a molecule-for-molecule basis, often linked to junk food consumption.
Host of The Drive podcast, interested in optimizing performance, health, longevity, and critical thinking.
Prominent researcher known for his work on aging and sirtuins, discussed in a previous podcast episode.
Researcher whose animal studies (mice) utilized elegant tracers to track NR metabolism, showing that most NR is converted to nicotinamide by the liver before reaching other tissues as NAD+.
Entrepreneur and venture capitalist known for posing thought-provoking questions about contrarian truths.
Guest on the podcast, holds a Ph.D. in nutrition science, devoted to creating information about nutrition, and has a unique historical perspective on scientific research.
Researcher from Cleveland Clinic, whose paper on TMAO gained significant attention.
Expert in functional medicine, involved in early discussions with Peter Attia and Chris Masterjohn regarding TMAO.
First author on a JAMA study that showed a 50% reduction in liver fat in Hispanic boys with biopsy-proven NASH after 8 weeks on a virtually zero-fructose diet.
More from Peter Attia MD
View all 322 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free